Skip to main content
. 2021 Jun 7;10(6):928. doi: 10.3390/antiox10060928

Figure 10.

Figure 10

The summary diagram is demonstrated. It is suggested that catechins could be an available candidate drug to meet the requirements, including (1) the direct inhibiting SARS-CoV replication, (2) the mild enhancement of CD8+ mediated adaptive immunity, (3) the decrease of cytokine storm, and (4) the promoting autophagy-dependent protective mechanism to ameliorate acute lung injury.